Avid Bioservices (CDMO) Projected to Post Quarterly Earnings on Wednesday

Avid Bioservices (NASDAQ:CDMO) is anticipated to post its quarterly earnings results after the market closes on Wednesday, April 23rd. Analysts expect Avid Bioservices to post earnings of ($0.04) per share for the quarter.

Avid Bioservices Trading Up 0.1 %

Shares of Avid Bioservices stock opened at $12.50 on Wednesday. The company has a debt-to-equity ratio of 3.58, a current ratio of 1.30 and a quick ratio of 0.92. Avid Bioservices has a 1 year low of $6.23 and a 1 year high of $12.51. The firm has a market cap of $799.18 million, a PE ratio of -5.23 and a beta of 1.39. The company has a 50 day simple moving average of $12.50 and a two-hundred day simple moving average of $12.01.

Avid Bioservices Company Profile

Avid Bioservices, Inc operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services.